$59.30-0.70 (-1.17%)
Taylor Morrison Home Corporation, together with its subsidiaries, operates as a homebuilder and land developer in the United States.
Taylor Morrison Home Corporation in the Consumer Cyclical sector is trading at $59.30. The stock is currently 18% below its 52-week high of $72.50, remaining 5.4% below its 200-day moving average. Technical signals show neutral RSI of 40 and bearish MACD signal, explaining why TMHC maintains its current current market pressure. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Taylor Morrison Home Corporation, together with its subsidiaries, operates as a homebuilder and land developer in the United States. It designs, builds, and sells single, and multifamily detached and attached homes in markets for entry-level, move-up...
A number of stocks fell in the afternoon session after the renewed Middle East tensions pushed Treasury yields back toward nine-month highs, threatening to drive 30-year mortgage rates higher and further damage already-fragile buyer demand.
Taylor Morrison Home (NYSE:TMHC) reported first-quarter 2026 results that management said reflected the benefits of its diversified strategy, disciplined execution, and positioning in core locations, while acknowledging a backdrop of higher mortgage rates and consumer caution. First-quarter perform
Check out the companies making headlines yesterday:
Taylor Morrison Home Corporation recently reported past first-quarter 2026 results, with revenue of US$1,387.09 million and net income of US$98.63 million, reflecting lower year-over-year earnings per share despite beating analyst expectations on adjusted metrics. At the same time, the company is pushing ahead with long-term growth plans, including over 1,750 planned homes across two new Port St. Lucie communities under its expanding Esplanade resort lifestyle brand. We’ll now examine how...
Homebuilder Taylor Morrison Home (NYSE:TMHC) reported Q1 CY2026 results topping the market’s revenue expectations, but sales fell by 26.8% year on year to $1.39 billion. Its non-GAAP profit of $1.12 per share was 33.4% above analysts’ consensus estimates.